Liquidia stock jumps 13% after $148M Yutrepia sales update; what investors watch next
Liquidia shares jumped 12.9% to $35.86 Friday after the company reported preliminary 2025 Yutrepia sales of $148.3 million and year-end cash of $190.7 million. The stock hit a 52-week high of $38.16. Investors await a Jan. 14 J.P. Morgan conference update and news on ongoing patent litigation with United Therapeutics.